Vitamin D in prostate cancer / 亚洲男科学杂志(英文版)
Asian Journal of Andrology
;
(6): 244-252, 2018.
Article
in English
| WPRIM
| ID: wpr-1009601
ABSTRACT
Signaling through the vitamin D receptor has been shown to be biologically active and important in a number of preclinical studies in prostate and other cancers. Epidemiologic data also indicate that vitamin D signaling may be important in the cause and prognosis of prostate and other cancers. These data indicate that perturbation of vitamin D signaling may be a target for the prevention and treatment of prostate cancer. Large studies of vitamin D supplementation will be required to determine whether these observations can be translated into prevention strategies. This paper reviews the available data in the use of vitamin D compounds in the treatment of prostate cancer. Clinical data are limited which support the use of vitamin D compounds in the management of men with prostate cancer. However, clinical trials guided by existing preclinical data are limited.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Prostatic Neoplasms
/
Vitamin D
/
Vitamin D Deficiency
/
Calcifediol
/
Calcitriol
/
Signal Transduction
/
Antineoplastic Combined Chemotherapy Protocols
/
Ergocalciferols
/
Clinical Trials as Topic
Limits:
Humans
/
Male
Language:
English
Journal:
Asian Journal of Andrology
Year:
2018
Type:
Article
Similar
MEDLINE
...
LILACS
LIS